he purpose of this report was to update the 2006 International League Against Epilepsy (ILAE) report and identify the level of evidence for long-term efficacy or effectiveness for antiepileptic drugs (AEDs) as initial monotherapy for patients with newly diagnosed or untreated epilepsy. All applicable articles from July 2005 until March 2012 were identified, evaluated, and combined with the previous ysis (Glauser et al., 2006) to provide a comprehensive update.
The prior ysis methodology was utilized with three modifications: (1) the detectable noninferiority boundary approach was dropped and both failed superiority studies and prespecified noninferiority studies were yzed using a noninferiority approach, (2) the definition of an adequate comparator was clarified and now includes an absolute minimum point estimate for efficacy/effectiveness, and (3) the relationship table between clinical trial ratings, level of evidence, and conclusions no longer includes a recommendation column to reinforce that this review of efficacy/evidence for specific seizure types does not imply treatment recommendations.
This evidence review contains one clarification: The commission has determined that class I superiority studies can be designed to detect up to a 20% absolute (rather than relative) difference in the point estimate of efficacy/effectiveness between study treatment and comparator using an intent-to-treat ysis. Since July, 2005, three class I randomized controlled trials (RCT) and 11 class III RCTs he been published. The combined ysis (1940-2012) now includes a total of 64 RCTs (7 with class I evidence, 2 with class II evidence) and 11 meta-yses.
New efficacy/effectiveness findings include the following: levetiracetam and zonisamide he level A evidence in s with partial onset seizures and both ethosuximide and valproic acid he level A evidence in children with childhood absence epilepsy.
There are no major changes in the level of evidence for any other subgroup. Levetiracetam and zonisamide join carbamazepine and phenytoin with level A efficacy/effectiveness evidence as initial monotherapy for s with partial onset seizures. Although ethosuximide and valproic acid now he level A efficacy/effectiveness evidence as initial monotherapy for children with absence seizures, there continues to be an alarming lack of well designed, properly conducted epilepsy RCTs for patients with generalized seizures/epilepsies and in children in general.
These findings reinforce the need for multicenter, multinational efforts to design, conduct, and yze future clinically relevant adequately designed RCTs. When selecting a patient's AED, all relevant variables and not just efficacy and effectiveness should be considered.
查看信源地址
- 2022-05-022013年国际抗癫痫联合会抗癫痫泻药使用指南
- 2022-04-25癫痫病的病因是哪些因素受到影响的呢
- 2022-04-11著名女演员愤怒地告诉莆田妇科医院 要求在全国媒体上公开道歉
- 2022-02-21常见的癫痫病治疗新方法 选择合适的才好
- 2022-01-17癫痫病治疗的最佳整整
- 女生有妇科炎症,能自愈吗?
- 女人过早对夫妻不利
- 抗癫痫药物预防新发癫痫:任重而道远
- 著名女演员愤怒地告诉莆田妇科医院 要求在全国媒体上公开道歉
- CHINA-PHARM 2013
- 手术学习:颅内脊索瘤内镜下三脑室入路治疗
- 如何诊断妇科炎症?做什么检查?
- 20140115健康生活视频全集:丁健华谈到便秘的危害
- 女性体检 女性妇科常见六大疾病需及时检查
- 你在中国当医生的五少痛点?
- 我的情绪怎么了:为什么我这么容易玻璃心?
- 李敖病逝!面对医疗展示勇士的姿态
- 每个女人都是江湖……
- 在泰国,女性子宫实际上需要这些试管婴儿手术
- 脑膜炎球菌疫苗MenQuadfi欧盟批准
- Diabetologia:注意了!熬夜,睡眠质量差,血糖波动大!
- 精彩幻灯:一网打尽妇科常见病
- 子宫腺肌病是什么?有哪些危害?应该如何预防?
- 他们在对抗子宫腺肌病的路上走了太多弯路!
- 谣言:你相信痛经的事情有多少?
- J Cell Physiol:草莓对子宫肌瘤患者有益
- 你知道药浴治疗 14种有效药浴吗?
- 洪涝灾害的淹溺如何急救?心肺复苏遵循这4步!
- A&R: Semaphorin3B 在血清诱导的关节炎模型中发挥核心作用,减少类风湿性关节炎患者
- PRS:注射液能促进脂肪干细胞的脂肪分化吗?
- 心率多少正常 如何保持正常心率不变
- 情产生性对性健康更有益
- 胀痛不一定是一种疾病。不要太担心这三种情况
- 记好癫痫日记,让求医事半功倍
- 根治癫痫病的步骤都有什么
- 药物病患癫痫病怎么样
- 会议福利来袭:神经领域书刊全部限免
- 成年人发生癫痫病的原因有哪些?
- 枕叶痉挛的发病类型 枕叶痉挛的临床症状
- NeuroImage:纤维球成像可用做癫痫疾病进展
- 癫痫病进食什么药好点
- 成年人癫痫病的怎么治疗
- 孩子癫痫病吃什么食物对病情好
- 癫痫的副作用 睡觉中犯癫痫会有哪些表现
- 21世纪癫痫日 | 科学防治 规范诊疗 告别癫痫